StromalScore, ImmuneScore, and ESTIMATEScore were significantly lower in “high ATP6AP1 expression” breast cancer patients relative to “low ATP6AP1 expression” breast cancer patients (p < 0.001; Figure 7A). Here, ATP6AP1 is linked to breast carcinoma.